GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (ASX:IMU) » Definitions » Short-Term Capital Lease Obligation

Imugene (ASX:IMU) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Imugene Short-Term Capital Lease Obligation?

Imugene's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Imugene's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.19 Mil) but then declined from Jun. 2023 (A$0.19 Mil) to Dec. 2023 (A$0.00 Mil).

Imugene's annual Short-Term Capital Lease Obligation increased from Jun. 2022 (A$0.18 Mil) to Jun. 2023 (A$0.19 Mil) and increased from Jun. 2023 (A$0.19 Mil) to Jun. 2024 (A$0.91 Mil).

Imugene Short-Term Capital Lease Obligation Historical Data

The historical data trend for Imugene's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imugene Short-Term Capital Lease Obligation Chart

Imugene Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.11 0.18 0.19 0.91

Imugene Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 - 0.19 - 0.91

Imugene Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Imugene Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Imugene's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Imugene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (ASX:IMU) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
ASX:OPT ASX:LTP ASX:PYC ASX:RAC ASX:IMM ASX:DXB ASX:ALA ASX:BOT ASX:RCE ASX:PIQ OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX
Traded in Other Exchanges
IUGNF:USA
Address
4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Website
https://www.imugene.com
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.

Imugene Headlines

No Headlines